Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Neuroblastoma 4Colonic Neoplasms 4Stomach Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Osteosarcoma 3Neoplasms 3Gastrointestinal Stromal Tumors 3Dendritic Cell Sarcoma, Interdigitating 3Carcinoma, Hepatocellular 3Recurrence 2Optic Nerve Glioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasm Metastasis 2Nasopharyngeal Neoplasms 2Melanoma 2Medulloblastoma 2Lymphoma, Large B-Cell, Diffuse 2Gallbladder Neoplasms 2Familial ependymoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Burkitt Lymphoma 2Bile Duct Neoplasms 2Astrocytoma 2Appendiceal Neoplasms 2Wilms Tumor 1Vipoma 1Testicular Neoplasms 1Teratoma 1

Interventions

trifluridine tipiracil drug combination 1Oxaliplatin 1Nivolumab 1Magnetic Resonance Spectroscopy 1Leucovorin 1Fluorouracil 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenomatous Polyposis Coli × Oxaliplatin × Sarcoma × Clear all
NCT05919264 2026-05-28

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Parabilis Medicines, Inc.

Phase 1/2 Recruiting
595 enrolled
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Craniopharyngioma, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡